No Detail Found!

Therapeutic effect of Xihuang capsules in combination with low-power high-intensity focused ultrasound on granulomatous mastitis and its impact on macrophage (CD68) and proliferative (Ki67) markers

Author(s)
Xiaolong Li Department of Breast Surgery, Shijiazhuang Fourth Hospital,Shijiazhuang,China
Hang Li Department of Breast Surgery, Shijiazhuang Fourth Hospital,Shijiazhuang,China
Chunling Mu Department of Breast Surgery, Shijiazhuang Fourth Hospital,Shijiazhuang,China
Haonan Li Department of Breast Surgery, Shijiazhuang Fourth Hospital,Shijiazhuang,China
Qianqian Du Department of Breast Surgery, Shijiazhuang Fourth Hospital,Shijiazhuang,China
Wei Liu Department of Breast Surgery, Shijiazhuang Fourth Hospital,Shijiazhuang,China
Abstract
Granulomatous mastitis (GM) is a chronic inflammatory breast disease with a high recurrence rate and low effectiveness of the traditional treatments. This randomized controlled trial compared the effectiveness of the combined use of Xihuang Capsules and low-power High-Intensity Focused Ultrasound (HIFU) and their impact on macrophage infiltration (CD68) and cell proliferation (Ki67). Sixty women with histologically proven GM were randomized to experimental (HIFU + Xihuang) or control (HIFU alone) groups (n=30 each group). Follow-up was for 12 weeks and recurrence at 6 months. Compared with controls, the combination group experienced more lesion reduction (3.50±0.79 cm to 0.92±0.42 cm vs. 3.42±0.88 cm to 1.85±0.60 cm, p<0.001), improved complete resolution (86.7% vs. 60.0%, p = 0.023), earlier resolution (6.2±1.4 vs. 9.1±1.8 weeks, p<0.001) and greater pain reduction (VAS: 7.2±1.1 to 1.3±0.6 vs. 7.0±1.3 to 2.8±0.9, p<0.001). Immunohistochemistry also demonstrated marked reductions in CD68+ macrophages and Ki67 index, both blindly graded. Recurrence at 6 months reduced with combination therapy (6.7% vs. 20.0%, p=0.098). Both treatments were well tolerated. These data indicate that Xihuang Capsules plus low-power HIFU produce faster regression of lesions, disappearance of symptoms and modulation of macrophage infiltration and cell proliferation in GM, with tendency of decreased recurrence. 
Publication Details
Page(s) 2453-2461
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 6, Year: 2025

Request the full text from PASTIC

Keywords
Combination therapy, Xihuang capsules, Low-power high-intensity focused ultrasound, Granulomatous mastitis, Proliferation marker (Ki67), Macrophage marker (CD68)
References
Azzam MI,Alnaimat F,Al-Nazer MW,Awad H,Odeh G,Al-Najar M,Alsayed S M .2023 .Idiopathic granulomatous mastitis: Clinical, histopathological and radiological characteristics and management approaches. Rheumatol. Int., 43(10) : 1859-69.
Aydin I,Kesicioglu T,Vural S T .2021 .Idiopathic granulomatous lobular mastitis: An imitation of breast carcinoma. Cureus, 13(5) : e15206.
Cui L,Sun C,Guo J,Zhang X .2024 .Pathological manifestations of granulomatous lobular mastitis. Front. Med, 11 : 1326587.
Danforth DN .2021 .The role of chronic inflammation in the development of breast cancer. Cancers, 13(15) : 3918.
De Maio A,Alfieri G,Mattone M,Ghanouni P,Napoli A,De Maistre E A .2023 .High-intensity focused ultrasound surgery for tumor ablation: A review of current applications. Radiol. Imaging Cancer, 6(1) : e230074.
Devi RS,Kumar A,Singh A,Durgapal P,Kishore S,Phulware RH .2024 .Cytopathological and histopathological correlation of granulomatous mastitis: A series of 30 cases. , 41 : S39.
Dilaveri C,Degnim A,Lee C,DeSimone D,Moldoveanu D,Ghosh K,Abbasvandi F K .2024 .Idiopathic granulomatous mastitis. Breast J., : 6693720.
Ebadi AG,Selamoglu Z AG .2025 .Exploring the role of herbal medicines in modern pharmacology and drug development. Lat. Am. J. Pharm., 44(4) : 401-406.
Esmaeil NK,Salih AM .2024 .Investigation of multiinfections and breast disease comorbidities in granulomatous mastitis. Ann. Med, 86 : 1881-6.
Guimaraes AR,Marques AP,Sarmento A .2025 .Cystic neutrophilic granulomatous mastitis associated with Corynebacterium: A systematic review of clinical, pathological and therapeutic insights. Rev. Senol. Patol. Mam., 38(3) : 100704.
Hua C,Li F,Shi Y,Xu Y,Zhu M,Wang Y,Zhou X Y .2024 .Long-term outcomes of traditional Chinese medicine in the treatment of granulomatous lobular mastitis: A two-year follow-up study on recurrence and new occurrence rates with analysis of risk factors. J. Inflamm. Res., 31 : 7389-99.
Kong C,Zhang C,Wu Y,Zeng Z,Yu H,Zeng J,Lei S,He J .2020 .The expression and meaning of CD68, CD163, CD57 and IgG4 in granulomatous lobular mastitis. Gland Surg., 9(4) : 936.
Li H,Li B,Chen H,Liu X,Wang H,Zhang G,Lin L .2025 .Application of microwave ablation combined with Chai Hu Qing Gan Tang in the treatment of idiopathic granulomatous mastitis. Breast J., : 2731494.
Liang Z and Zhang L .2025 .Research progress of plasma cell mastitis. Immun. Inflamm. Dis., 13(4) : e70199.
Lou Y,Xu H,Lu Z,Wang B,Liu X,Li J .2024 .Immune regulation: A new strategy for traditional Chinese medicine-based treatment of granulomatous lobular mastitis. Front. Immunol., 15 : 1494155.
Ma P,Yuan L,Jia S,Zhou Z,Xu D,Huang S,Meng F,Zhang Z F .2024 .Lonicerae japonicae Flos with the homology of medicine and food: A review of active ingredients, anticancer mechanisms, pharmacokinetics, quality control, toxicity and applications. , 14 : 1446328.
Parperis K,Costi E,Philippou S,Hadi M,Derk CT M .2024 .Efficacy of disease-modifying antirheumatic drugs in the treatment of granulomatous mastitis: A systematic review. Rheumatol. Int., 44(11) : 2371-9.
Rad MA,Sheybani F,Gharib M,Aghel E,Emadzadeh M,Mottaghi M M .2025 .Coexistence of lobular granulomatous mastitis and breast cancer: Case report and case-based literature review. Int. J. Surg. Case Rep., 111628., : .
Shojaeian F,Haghighat S,Abbasvandi F,Tehrani AH,Najafi NN,Zandi A,Olfatbakhsh A,Sharifi M,Hashemi E,Nafissi N,Najafi S N .2024 .Refractory and recurrent idiopathic granulomatous mastitis treatment: Adaptive, randomized clinical trial. J. Am. Coll. Surg., 238(6) : 1153-65.
Sarmadian R,Safi F,Sarmadian H,Shokrpour M,Almasi-Hashiani A .2024 .Treatment modalities for granulomatous mastitis, seeking the most appropriate treatment with the least recurrence rate: A systematic review and meta-analysis. Eur. J. Med. Res., 29(1) : 164.
Wang P,Sun JZ,Fang HY,Yang DJ,Ren GS,Li J .2024 .Optimal timing for corticosteroid therapy in idiopathic granulomatous mastitis: A retrospective analysis highlighting early intervention efficacy. J. Inflamm. Res., 31 : 9617-24.
Wijesinghe A,Lakmal K,Senevirathna J,Wijetilake B,Fernando JL,Jayarajah U,De Silva A,Wijesinghe K A .2024 .The use of intralesional corticosteroids in idiopathic granulomatous mastitis: A systematic review. Eur. J. Breast Health, 20(4) : 233.
Wu X,Yang L,Li Z,Yin H,Chen W .2025 .Clinical efficacy of ultrasound-guided high-intensity focused ultrasound ablation for treating breast fibroadenoma of different sizes: Gynecol. , 14(1) : 72-80.
Xie L,Feng J,Gao Q,Qu W,Shao S,Sun J,Wu X,Wan H X .2025 .The autoimmune profiles in the etiopathogenesis of granulomatous lobular mastitis. Immunobiology, 230(2) : 152878.
0

Citations

0

Downloads

112

Views